Xolair Related Clinical Trials
Study to Evaluate the Effect of Xolair(Omalizumab) on Improving the Tolerability of Specific Immunotherapy in Patients With at Least Moderate Persistent Allergic Asthma Inadequately Controlled With Inhaled Corticosteroids [Completed]
Effect of Ozone on Airway Inflammation in Allergic Asthmatics Treated With Omalizumab [Terminated]
Safety and Efficacy Study of Omalizumab Given Prior to Immunotherapy [Completed]
A Continued Access Protocol to Provide Xolair to Patients With Severe Allergic Asthma [Completed]
Effects of Anti-IgE Antibody Omalizumab on Patients With Chronic Sinusitis [Withdrawn]
An Extension Study of Xolair in Moderate to Severe, Persistent Asthma Patients Who Completed Study Q2143g [Completed]
The Effect of Xolair (Omalizumab) on Allergy Blood Cells [Recruiting]
Effect of Xolair on Airway Hyperresponsiveness [Recruiting]
The Safety and Utility of Skin Testing With Xolair (Omalizumab) and Placebo Omalizumab (Formulation Excipients) [Recruiting]
Non-Invasive Ways to Evaluate Lung Disease After Treatment With Xolair [Recruiting]
A Safety and Efficacy Study of Xolair in Peanut Allergy [Terminated]
Efficacy and Safety of Omalizumab in Bullous Pemphigoid [Recruiting]
Omalizumab (Xolair) and Allergy Shots For the Treatment of Seasonal Allergies [Completed]
Therapeutic Utility of Xolair in Patients Undergoing Aspirin Desensitization [Recruiting]
A Pilot Study of the Treatment of Eosinophilic Esophagitis With Omalizumab [Recruiting]
A Study of Xolair in Peanut-Allergic Subjects Previously Enrolled in Study Q2788g [Active, not recruiting]
Immunologic Basis of Anti-IgE Therapy (Study II: On Patients With Asthma) [Recruiting]
The Effect of Xolair on Inhibiting Leukotriene and Cytokine (IL-4 and IL-13) Release From Blood Basophils [Active, not recruiting]
Efficacy/ Safety of Omalizumab in Patients With Seasonal Allergic Asthma and Seasonal Allergic Rhinoconjunctivitis [Active, not recruiting]
Safety and Tolerability of Omalizumab in Patients With Mild to Moderate Asthma [Recruiting]
Effect of Omalizumab (Xolair) in Treatment of Patients With AERD and Allergy Asthma [Recruiting]
The Effect of Omalizumab on Responses to Cat Allergen Challenge [Recruiting]
Xolair in Patients With Chronic Sinusitis [Recruiting]
A Compassionate Access Protocol to Assess the Safety of XolairTM (Omalizumab) in Patients (≥ 6 Years Old) With Severe Allergic Asthma Who Remain Symptomatic Despite Optimal Therapy [Enrolling by invitation]
Omalizumab to Treat Hyper-IgE (Job's) Syndrome [Recruiting]
Omalizumab in Adult and Adolescent Patients With Severe Persistent Allergic Asthma [Recruiting]
Long-Term Study of IGE025 in Moderate to Severe Bronchial Asthma. [Completed]
Efficacy and Safety of Omalizumab in Children (6 - <12 Years) With Moderate-Severe, Inadequately Controlled Allergic Asthma [Active, not recruiting]
Safety and Tolerability of Omalizumab in Adults and Adolescents With Severe Allergic Asthma [Completed]
Six Months, Open Label Study to Assess Safety and Immunogenicity of Omalizumab Liquid Formulation in Adolescents (>12 Years) and Adults With Moderate to Severe Persistent Allergic Asthma [Recruiting]
Safety and Tolerability of Omalizumab in Poorly Controlled Moderate to Severe Asthma Patients [Completed]
A Pilot Study Investigating the Effect of Omalizumab (Xolair) in Work-Related Animal Induced Asthma [Not yet recruiting]
Omalizumab to Treat Eosinophilic Gastroenteritis [Active, not recruiting]
Study to Evaluate the Effect of Omalizumab on Improving the Tolerability of Specific Immunotherapy in Patients With Persistent Allergic Asthma [Completed]
Omalizumab Use and Asthma-Related Quality of Life in Patients With Severe Persistent Allergic Asthma [Recruiting]
Non-Invasive Measures of Effects of Xolair in Asthma [Not yet recruiting]
An Observational Study of the Use and Safety of Xolair During Pregnancy [Recruiting]
Study of Omalizumab in Moderate to Severe Bronchial Asthma [Completed]
A Study to Evaluate the Safety of Xolair in Moderate to Severe Persistent Asthma Patients (ALTO) [Completed]
Effect of Omalizumab on Expression of IgE Receptors in Adults With Severe, Inadequately Controlled Allergic Asthma [Active, not recruiting]
Efficacy and Safety of Omalizumab in Patients With Severe Persistent Asthma [Completed]
Efficacy of Omalizumab as Add on Therapy for Minority Patients With Moderate to Severe Asthma [Recruiting]
Efficacy of Omalizumab in Adults (18-60 Years of Age) With Moderate-Severe, Persistent Allergic Asthma, Despite Receiving Inhaled Corticosteroids and Long Acting Beta-Agonists [Recruiting]
A Study of Efficacy of New Doses of Xolair to Protect From Allergen Challenge in Groups of Asthma Patients Defined by IgE Levels [Recruiting]
A Study of Omalizumab in Preventing Bronchoconstriction Following Environmental Cat Dander Exposure in Patients With Cat Dander-Induced Asthma (AERO) [Recruiting]
A Study of Xolair to Evaluate Effectiveness and Long-Term Safety in Patients With Moderate to Severe Asthma [Active, not recruiting]
A Study to Evaluate the Efficacy of Xolair in Atopic Asthmatics [Recruiting]
A Study of Omalizumab in the Prevention of Allergen Induced Airway Obstruction in Adults With Mild Allergic Asthma (AQUA) [Recruiting]
Effect of Anti-IgE in Chronic Urticaria [Completed]
Efficacy and Safety of Omalizumab in Adults (18-70 Years) With Moderate to Severe Chronic Urticaria Who Exhibit IgE Against Thyreoperoxidase [Recruiting]
The Effect of Omalizumab on Airway Responsiveness to Adenosine in Patients With Poorly Controlled Asthma [Active, not recruiting]
Soluble CD23 Expression in Asthma Patients Treated With OMA [Terminated]
ICATA Asthma Mechanistic Study [Active, not recruiting]
Inner-City Anti-IgE Therapy for Asthma
A Description of Inflammatory Cell Types In Moderate to Severe Pediatric Asthma: Eosinophilic and Non Eosinophilic Sputum Markers While on Anti-IgE Therapy [Recruiting]
Impact of Asthma Treatments on Daily Activities [Recruiting]
Effect of Anti-IgE in Non-Allergic Asthma [Recruiting]
Immune Dysfunction in Allergic Asthma [Recruiting]
|
